Latest posts by Lawrence F Muscarella PhD (see all)
- A Duodenoscope Has Been Linked to ‘Probable Transmission’ of a Colistin-Resistant Superbug In January, the FDA had issued a safety alert reporting a "design issue" with this endoscope "that could increase the risk of patient infection." - December 8, 2017
- FDA Clears A Duodenoscope with a Detachable Cap Almost 20 years ago, the FDA cleared two other duodenoscope models with a reusable distal cover for sale in the U.S. - September 25, 2017
- Air Force Advises 135 Patients of HIV, Hepatitis Infection Risk a Year Later A number of questions about this lapse remain unanswered. - June 26, 2017
“The most comprehensive series of articles ever written about the risk of ‘superbug’ outbreaks during gastrointestinal endoscopy.”
“The series that started the national discussion about the risk of ‘superbug’ infections following GI endoscopy.”
Click here to read a free copy of Dr. Muscarella’s peer-reviewed article, which foresaw the deadly outbreaks that soon followed:
- “Risk of transmission of carbapenem-resistant Enterobacteriaceae and related ‘superbugs’ during gastrointestinal endoscopy” (World J Gastrointest Endosc 2014; 6:457-474).
The following series of more than two dozen articles by Dr. Muscarella discuss a number of recent outbreaks of “CRE” — or, carbapenem-resistant Enterobacteriaceae — following gastrointestinal (GI) endoscopy:
1. Executive Summary: “‘Updated’ Guidance for the Prevention of Multidrug-Resistant ‘Superbugs’ Following Endoscopy” [Free temporarily]
2. “FDA Recalls All Custom Ultrasonics System 83 Plus Automated Endoscope Reprocessors” [Free temporarily]
24. “GI Endoscopy: Pushed Beyond its Reprocessing Limits?” — click here.